Age13 yrs
Real estate1 parcel · 126 m²
Conclusion
the dossier summarised in one paragraphThe file of MITHRA PHARMACEUTICALS CDMO contains 1 judicial reorganisation, as published in the Belgian State Gazette. The computed 12-month bankruptcy probability is 8.2% (elevated). No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone8.2%
Elevated
0%0,5%1,5%4%10%≥25%
Judicial reorganisation on record
+Multiple establishment units
+Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Insolvency timeline
1 events24-06-2024
Judicial reorganisation
Extension
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publicationslatest 24-06-2024
1
publications in the State GazetteAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
1 signalIn judicial reorganisation
Ongoing reorganisation procedure — the company is restructuring under court protection.
Administrative Flags
0 events
No administrative flags
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201
Primary activity highlighted.
Names & trade names
| Legal nameFR | MITHRA PHARMACEUTICALS CDMO |
Registered office
Rue Saint-Georges 5
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.